Navigation Links
Commentary in The Lancet on the Declaration of Istanbul Sees Organ Transplantation Worldwide Threatened by Organ Trafficking and Transplant Tourism and Commercialism
Date:7/3/2008

BOSTON, Massachusetts, July 3 /PRNewswire/ -- The July 5 issue of the leading medical journal, The Lancet, highlights the Declaration of Istanbul on Organ Trafficking and Transplant Tourism, an important affirmation of ethical principles and practices adopted on May 2, 2008, at an International Summit of more than 150 healthcare professionals, officials, scientists, ethicists and legal scholars from 78 countries and 20 international organizations. A Commentary, authored by the 32-member Steering Committee of the Istanbul Summit, describes how the policies advocated by the Declaration will help to combat the trafficking of people as a source of human organs for transplantation, and the transplant tourism which depends on organ sales and undermines countries' efforts to meet the health needs of their own populations. The commentary and the declaration are available at the following Multimedia News release link, please click: http://www.prnewswire.com/mnr/transplantationsociety/33914/

Organ commercialism, which targets vulnerable populations (such as illiterate and impoverished persons, undocumented immigrants, prisoners, and political or economic refugees) in resource-poor countries, has been condemned by international bodies such as the World Health Organization for decades. Yet in recent years, as a consequence of the increasing ease of internet communication and the willingness of patients in rich countries to travel and purchase organs, organ trafficking and transplant tourism have grown into global problems. For example, as of 2006, foreigners received two-thirds of the 2000 kidney transplants performed annually in Pakistan.

The Declaration of Istanbul proclaims that the poor who sell their organs are being exploited, whether by richer people within their own countries or by transplant tourists from abroad. Moreover, transplant tourists risk physical harm by unregulated and illegal transplantation. Participants in the Istanbul Summit concluded that transplant commercialism and tourism and organ trafficking should be prohibited. And they also urged their fellow transplant professionals, individually and through their organizations, to put an end to these unethical activities and foster safe, accountable practices that meet the needs of transplant recipients while protecting donors.

The Commentary points out that countries from which transplant tourists originate, as well as those to which they travel to obtain transplants, are just beginning to address their respective responsibilities to protect their people from exploitation and to develop national self-sufficiency in organ donation. The authors expect that the Declaration will reinforce the resolve of governments and international organizations to develop laws and guidelines to bring an end to wrongful practices. "The legacy of transplantation is threatened by organ trafficking and transplant tourism. The Declaration of Istanbul aims to combat these activities and to preserve the nobility of organ donation. The success of transplantation as a life-saving treatment does not require-nor justify-victimizing the world's poor as the source of organs for the rich."

The Declaration of Istanbul has been endorsed by The Transplantation Society and the International Society of Nephrology, which sponsored the Summit meeting.


'/>"/>
SOURCE The Transplantation Society
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. The Lancet Global Health Network
2. The Lancet publishes first clinical trial data of a fully bioabsorbable drug-eluting stent
3. MediPurpose Sells 500 Millionth Safety Lancet to IMCO Member MMS Medical
4. New Lancet Study: Tobacco Control Measures Are Effective and Affordable Strategies to Reduce Chronic Disease Deaths Globally
5. Two studies published in the Lancet
6. Telecommunications Carriers Respond To Congress Declaration of April as National 9-1-1 Education Month
7. Figure Skater Peggy Fleming Teams With HealthSaver: Go Organic for Quality, Natural Food
8. Organ Donation: An Advancing Science Hindered by Supply Shortages
9. Latest Research Shows Strong Consumer Demand for Organic Foods
10. Immune Molecule Key to Preventing Organ Rejection
11. Target Debuts Organic Skin Care Line Uniquely Developed from African and Asian Natural Remedies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2017)... ... ... Despite its pervasiveness, many physicians are unfamiliar with how best to treat ... practice. Now, however, a timely review has been published in the Journal of ... NeuP and educating preclinical scientists on its diagnosis and choice of treatment. , The ...
(Date:6/20/2017)... Murfreesboro, Tennessee (PRWEB) , ... June 20, 2017 ... ... chronic care services, announced today that Claritas Capital, a Nashville-based private equity firm, ... to accelerate our expansion plans for some time, and Claritas Capital offers the ...
(Date:6/20/2017)... ... June 20, 2017 , ... Hayes, Inc., ... a new eBook titled “ 5 Questions to Ask Before Entering the Maze ... the Genetic Test Evaluation (GTE) team, the book explores the various types of ...
(Date:6/20/2017)... ... 20, 2017 , ... AMC Health , the leading provider of proven ... trials market. Similar to its approach in demonstrating positive outcomes in the healthcare market, ... proving the value of eVisits to support virtual studies. , In a ...
(Date:6/20/2017)... ... June 20, 2017 , ... With certifications and experience that puts ... NJ, Drs. Adam and Hal Kimowitz are currently accepting new patients at their practice ... can cause for some patients, which is why they offer the latest in modern ...
Breaking Medicine News(10 mins):
(Date:6/1/2017)... 2017 Nutriceutical Holdings (NH), parent company of ... and KD Pharma Group have decided to join forces ... Pharma Group. KD Pharma Group will become the largest ... the entire company. "We believe we have ... to growing the NH companies by providing us with ...
(Date:5/29/2017)... TEL AVIV, Israel, May 29, 2017  Cellect Biotechnology ... of innovative technology which enables the functional selection of ... financial results for the first quarter ended March 31 ... pleased with our accomplishments in the first quarter of ... the first quarter, we announced the treatment of the ...
(Date:5/23/2017)... 23, 2017  Leaf Healthcare, recognized for developing ... for pressure ulcer prevention, will unveil its comprehensive ... Critical Care Nurses, National Teaching Institute and Critical ... The Leaf Patient Monitoring System is the first ... environment.  The system seamlessly tracks patient movement throughout ...
Breaking Medicine Technology: